Bowden, Scott

Publishing since 1999 (Senior)

Has published 51 publications in 12 years

Number of publications published per year by Bowden, Scott. (Source : PubMed)

Distribution of publications types for Bowden, Scott. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Nguyen T, Thompson AJ, Bowden S, Croagh C, Bell S, Desmond PV, Levy M, Locarnini SA. Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia.  J. Hepatol.  2010;52;4  
•  Iser DM, Warner N, Revill PA, Solomon A, Wightman F, Saleh S, Crane M, Cameron PU, Bowden S, Nguyen T, Pereira CF, Desmond PV, Locarnini SA, Lewin SR. Co-infection of hepatic cell lines with HIV-hepatitis B virus (HBV) leads to an increase in intracellular hepatitis B surface antigen (HBsAg).  J. Virol.  2010  
•  Keating DT, Michaelides A, Mifsud NA, Bowden S, Kotsimbos TC. Respiratory epithelium: an unlikely reservoir for latent human polyomavirus infection but a likely portal of entry.  Transplantation  2010;89;5  
•  Egbunike JN, Shaw C, Porter A, Button LA, Kinnersley P, Hood K, Bowden S, Bale S, Snooks H, Edwards A. Streamline triage and manage user expectations: lessons from a qualitative study of GP out-of-hours services.  Br J Gen Pract  2010;60;572  
•  Bayliss J, Moser R, Bowden S, McLean CA. Characterisation of single nucleotide polymorphisms in the genome of JC polyomavirus using MALDI TOF mass spectrometry.  J. Virol. Methods  2010;164;1-2  
•  Mohamadkhani A, Sotoudeh M, Bowden S, Poustchi H, Jazii FR, Sayehmiri K, Malekzadeh R. Downregulation of HLA class II molecules by G1896A pre-core mutation in chronic hepatitis B virus infection.  Viral Immunol.  2009;22;5  
•  Eyre NS, Phillips RJ, Bowden S, Yip E, Dewar B, Locarnini SA, Beard MR. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.  J. Hepatol.  2009;51;3  
•  Matthews GV, Seaberg E, Dore GJ, Bowden S, Lewin SR, Sasadeusz J, Marks P, Goodman Z, Philp FH, Tang Y, Locarnini S, Thio CL. Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals.  AIDS  2009;23;13  
•  Bowden S, Shaw T. Hepatitis B: the case for combination therapy.  Curr Opin Investig Drugs  2009;10;8  
•  Miller ER, Hellard ME, Bowden S, Bharadwaj M, Aitken CK. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.  J. Infect.  2009;58;5  

[ See timeline ] [ See all publications ]